DUBLIN, Jan. 7, 2025 (Globe Newswire) — The “High Pressure Balloon Catheters Market by Type, Material, Application, End User, and Region” report has been added to ResearchAndMarkets.com's offering . This comprehensive research report focuses on global and regional market size and forecast from 2024 to 2035.
The global high-pressure balloon catheter market is estimated at USD 3.07 billion in 2024 and is expected to reach USD 7.87 billion by 2035, at a CAGR of 8.93 during the forecast period 2025-2035. %is. This market is expected to increase due to a number of factors, including the rising prevalence of peripheral arterial and cardiovascular diseases, advancements in catheter technology, increasing demand for minimally invasive procedures, rising healthcare costs and access to cutting-edge treatments. It is expected. Expansion in emerging markets.
The rising prevalence of cardiovascular disease and increasing hospitalizations for heart-related diseases are key drivers for the healthcare industry. According to a report by the British Heart Foundation, around 7.6 million people in the UK have heart disease, including more than 4 million men and 3.6 million women. Approximately 100,000 people are hospitalized each year due to heart attacks. Furthermore, as of September 2024, around 6.4 million people in the UK were living with heart disease, highlighting the growing demand for advanced medical treatments and interventions.
By type, the increasing prevalence of cardiovascular diseases and rising adoption of minimally invasive surgical procedures made the therapeutic segment the most profitable segment in the global high-pressure balloon catheter market in 2024. For example, Peru's General Directorate of Medicines, Supply and Pharmaceuticals has approved MicroPort's Firefighter NC Balloon Catheter, a new generation balloon catheter that is resistant to high pressure and capable of rapid exchange, for marketing registration in Peru in January 2023. I did. The diagnostic segment is projected to grow at the fastest CAGR during the forecast period due to rising demand for accurate imaging and diagnosis in interventional procedures.
By material, the nylon segment accounted for the highest revenue segment in the global high pressure balloon catheter market in 2024 due to the material's high strength, flexibility, and ability to withstand extreme pressure. For example, MicroPort Scientific Corporation reported in August 2023 that the U.S. Food and Drug Administration (FDA) had cleared the Firefighter NC Pro PTCA balloon catheter (Firefighter NC Pro) for sale. High-pressure balloon catheters are a new generation introduced by MicroPort Colonary. Furthermore, the polyester segment is projected to grow at the fastest CAGR during the forecast period due to enhanced biocompatibility, durability, and increasing usage in advanced catheter designs.
Cardiology segment is expected to be the segment with the highest revenue by application in the global high-pressure balloon catheter market in 2024 due to the increasing number of percutaneous coronary interventions and high prevalence of coronary artery disease worldwide. It became. For example, Peru's General Directorate of Medicines, Supply and Pharmaceuticals approved the commercial registration of MicroPort Scientific Corporation's self-developed coronary balloon catheter in January 2023. These include the Firefighter PTCA Balloon Catheter, the Firefighter NC Balloon Catheter, the Foxtrot Pro Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter, and the Foxtrot NC PTCA Balloon Catheter. A new type of balloon catheter that can withstand high pressures and allow rapid exchange is the Firefighter NC Balloon Catheter. Furthermore, the urology field is projected to grow at the fastest CAGR during the forecast period due to its expanding applications in the treatment of ureteral dilatation and urethral strictures.
By end user, the hospital segment became the highest revenue generating segment in the global high pressure balloon catheter market in 2024 due to the increasing number of complex surgical procedures and availability of advanced infrastructure. For example, in February 2023, SIS Medical AG announced that its OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilation catheter with “twin-wall” technology will be available in the United States. Furthermore, the ambulatory surgery center segment is projected to grow at the fastest CAGR during the forecast period due to increasing preference for outpatient surgery due to cost reduction and faster recovery time.
North America is expected to have the highest revenue share during the forecast period due to established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of chronic diseases requiring catheter-based interventions. . For example, in February 2023, SIS Medical AG, one of the world's leading manufacturers of interventional cardiac medicine, will introduce a percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter OPN NC with “twin-wall” technology to the United States. Then he announced. Furthermore, Asia-Pacific is expected to grow at the fastest CAGR during the forecast period due to rapid expansion of the medical sector, increasing investments in medical device manufacturing, and increasing prevalence of cardiovascular and urinary diseases in the region. It is predicted.
Report scope
Base year: 2024 Forecast period: 2025-2035
Research scope
Market Forecast by Type, Material, Application and End User Market Forecast for 5 Regions and 17+ Countries North America (United States and Canada) Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe) Asia Pacific ( Top 10: China), Japan, India, Australia, South Korea, Rest of Asia Pacific) Latin America (Brazil, Mexico, Argentina, Rest of Latin America) MEA (South Africa, GCC, Rest of MEA) Comprehensive company profiles of market players over Medtronic Boston Scientific Abbott Laboratories Johnson & Johnson Philips Healthcare Stryker Corporation B. Braun Melsungen AG Terumo Corporation Zimmer BiometSmith & NephewCook MedicalCardinal HealthEdwards LifesciencesMedline IndustriesLivaNova Accurate 20% free customization available to meet your requirements
High Pressure Balloon Catheters Market Analysis and Forecast by Type 2024-2035 (Revenue USD Billion)
High Pressure Balloon Catheter Market Analysis and Forecast by Material 2024-2035 (Revenue USD Billion)
High Pressure Balloon Catheters Market Analysis and Forecast by Application 2024-2035 (Revenue USD Billion)
Cardiology Urology Nephrology Others
High Pressure Balloon Catheters Market Analysis and Forecast by End User 2024-2035 (Revenue USD Billion)
Hospital Ambulatory Surgery Center (ASC) Specialty Clinic Others
key attributes
Report attribute details No. Number of pages 200 Forecast period 2023 to 2034 Estimated market value in 2023 (US$) 3.07 billion US$ Predicted market value by 2034 (US$) 7.87 billion US$ Average annual growth rate 8.9 % Target area worldwide
For more information on this report, please visit https://www.researchandmarkets.com/r/xc6azr.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
Global high pressure balloon catheter market
